What Is Sofwave™?

 

Sofwave™ is next-generation SUPERB™ (Synchronous Ultrasound Parallel Beam) ultrasound technology stimulates the production of new collagen and elastin fibers in order to treat wrinkles and sagging skin. The collagen and elastin remodeling process naturally lifts the neck, brow, and submental (under the chin) while improving fine lines, wrinkles, and cellulite appearance for the short term. Sofwave™ is non-invasive, and patients can return to their daily routine. The treatment is safe for men and women of all skin types, including darker skin of all ethnicities.

​

CAN SOFWAVETM BE USED ON THE BODY?

Yes, in addition to lifting the neck, brow, and submental, Sofwave™ has recently gained FDA clearance to include the short-term improvement of cellulite, providing practices with more ways to treat their patients with Sofwave™ and allowing patients to see a more comprehensive improvement in their skin quality.

​

HOW DOES SOFWAVETM DIFFER FROM OTHER EXISTING TECHNOLOGIES?
The more aggressive options can cause damage to the upper skin, which may require a more extended healing period and considerable downtime. In addition, there is a higher risk of side effects, including discoloration and discomfort.

​

HOW LONG IS THE TREATMENT?

A complete treatment can take as little as 30-45 minutes. Patients love that they can fit Sofwave™ into their active lifestyle at any time of the day with no sun sensitivity.

​

HOW MANY TREATMENTS ARE NEEDED?

Typically, the treatment protocol calls for 1-2 treatments, depending on the patient’s skin condition and the physician‘s recommendation.

​

WHEN CAN I EXPECT TO SEE RESULTS?

The collagen regeneration process can take up to 12 weeks. Patients are expected to see ongoing improvements in the 3-month period following their treatment. In Sofwave’s clinical trials, results have been shown after just 1 treatment.

​

ARE THERE ANY SIDE EFFECTS WITH SOFWAVETM?
Sofwave™ is designed to minimize downtime and optimize patient convenience:

- No bruising was reported during clinical testing.
- No penetration of the skin is required.
- No device-related adverse events were reported in the multi-center clinical studies.
- None of the patients experienced persistent pain or tenderness that would delay a return to          normal activities.